WHO ICTRP trial
Botulinum toxin type A injections in stiff knee gait.
NL-OMON29171 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON29171 |
|---|---|
| Public title | Botulinum toxin type A injections in stiff knee gait. |
| Scientific title | The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gait. |
| Primary sponsor | Roessingh Research and Development Roessinghsbleekweg 33 7577 AH Enschede |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | In the Netherlands live about 18.000 Cerebro Vascular Accident (CVA)-patients which discover problems with walking caused by insufficient footclearance. Causes of problems with the footclearance during the swing phase of gait are a… |
| Interventions | Botulinum toxin type A injections (Botox®). Botox® is a neurotransmitter which reduce the release of acetylcholine. This causes a muscle paralysis for 12 weeks. Botulinum toxin type A is injected at 6 points in the m. rectus femoris (200U)… |
| Registration date | Jan 18, 2010 |
| Target size | 26 |
| Secondary IDs | NL2052;NTR2169;EudraCT : 2009-018226-29;ISRCTN wordt niet meer aangevraagd. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: